Korean J Fam Pract. 2017; 7(6): 926-932  https://doi.org/10.21215/kjfp.2017.7.6.926
Severity of Disability and Antihypertensive Medication Adherence in Korea
Seung Jae Kim1, Ho Chun Choi2,*, Cheol Min Lee2, Seung-Won Oh2, Hee-Kyung Joh3,4, Bumjo Oh5, Oh Deog Kwon1, Arang Lee1, Kwang Ho Oh1
1Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine; 2Department of Family Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul National University College of Medicine; 3Department of Medicine, Seoul National University College of Medicine; 4Department of Family Medicine, Seoul National University Health Service Center; 5Department of Family Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea
Ho Chun Choi
Tel: +82-2-2112-5745, Fax: +82-2-2114-5794
E-mail: skyho331@gmail.com
Received: July 6, 2017; Revised: September 3, 2017; Accepted: September 15, 2017; Published online: December 20, 2017.
© Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: Disabled patients exhibit poor antihypertensive medication adherence. In the absence of representative field studies, we investigated the differences and factors related to antihypertensive medication adherence between disabled and non-disabled people.
Methods: A sample set equivalent to 2% of the total Korean population, based on the National Health Insurance Service-National Sample Cohort for 2008 to 2013, included all patients over 20 years of age on antihypertensive drug therapy for hypertension for at least one year. The subjects were divided into three groups according to severity of disability: no disability (n=134,074), mild disability (n=3,219), or severe disability (n=13,527).
Results: Medication adherence was compared between groups. Medication, comorbidities, and socioeconomic factors were evaluated using stepwise adjustment to determine the main factors. The odds ratios of socioeconomic factors were analyzed using logistic regression. The medication possession ratio was 80.9% in those with no disability, 73.7% in those with mild disability, and 78.6% in those with severe disability. When adjusted for socioeconomic factors, the differences in medication adherence between the three groups were clinically insignificant. When compared with nondisabled patients, the odds ratios for receiving medical assistance or having low income were 5.1 and 1.8 (95% confidence interval, CI), respectively, in those with mild disability, and 1.6 and 1.1 (95% CI) in those with severe disability.
Conclusion: Disabled patients exhibit lower adherence to antihypertensive medication than nondisabled patients. Socioeconomic factors have a greater influence on adherence than other factors.
Keywords: Disabled Persons; Antihypertensive Drugs; Medication Adherence; Socioeconomic Factors
References
  1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva:World Health Organization; 2003.
  2. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
    Pubmed KoreaMed CrossRef
  3. Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2013; 36: 1000-5.
    Pubmed CrossRef
  4. Hong JS, Kang HC. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care 2011; 49: 378-84.
    Pubmed CrossRef
  5. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-35.
    Pubmed CrossRef
  6. Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013; 309: 2105-6.
    Pubmed KoreaMed CrossRef
  7. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy 2014; 7: 35-44.
    Pubmed KoreaMed
  8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-97.
    Pubmed CrossRef
  9. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol 2008; 128: 392-8.
    Pubmed CrossRef
  10. Morin D, Mérineau-Côté J, Ouellette-Kuntz H, Tassé MJ, Kerr M. A comparison of the prevalence of chronic disease among people with and without intellectual disability. Am J Intellect Dev Disabil 2012; 117: 455-63.
    Pubmed CrossRef
  11. Havercamp SM, Scandlin D, Roth M. Health disparities among adults with developmental disabilities, adults with other disabilities, and adults not reporting disability in North Carolina. Public Health Rep 2004; 119: 418-26.
    Pubmed KoreaMed CrossRef
  12. Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 2005; 47: 171-6.
    Pubmed CrossRef
  13. Park JH, Park JH, Lee SY, Kim SY, Shin Y, Kim SY. Disparities in antihypertensive medication adherence in persons with disabilities and without disabilities:results of a Korean population-based study. Arch Phys Med Rehabil 2008; 89: 1460-7.
    Pubmed CrossRef
  14. Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among medicare myocardial infarction survivors. Am Heart J 2012; 164: 425-33.e4.
    Pubmed KoreaMed CrossRef
  15. Disability rating table, Enforcement Rule of Welfare Act for the disabled [Internet]. Seoul: Korea Ministry of Government Legislation; 2015 [cited 2015 Aug 3].
  16. Tajouri TH, Driver SL, Holmes DR Jr. 'Take as directed'--strategies to improve adherence to cardiac medication. Nat Rev Cardiol 2014; 11: 304-7.
    Pubmed
  17. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277: 728-34.
    Pubmed CrossRef
  18. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5.
    Pubmed CrossRef
  19. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16: 110-7.
    Pubmed
  20. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764-71.
    CrossRef
  21. Kim TW. The poverty and inequality of disabled people. Health Welf Polic Forum 2010: 20-9.
  22. Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health 2002; 92: 1120-4.
    Pubmed KoreaMed CrossRef
  23. Park JH, Shin Y, Lee SY, Park JH. Antihypertensive drug medication adherence of people with disabilities and its affecting factors in Korea. J Prev Med Public Health 2007; 40: 249-58.
    Pubmed CrossRef


This Article

e-submission

Archives